ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.495
0.00%
Bitcoin
98,311.65
0.10%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Unum Group (U1NM34) Quote

Unum Group

Unum Group (U1NM34)

BOV
437.00
0.00
(0.00%)
Closed January 05 3:55PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
437.00
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
207.48 52 Week Range 469.95
Market Cap
85.235B
Previous Close
437.00
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
18
Shares Outstanding
195,046,000
Dividend Yield
1.51%
PE Ratio
11.10
Earnings Per Share (EPS)
6.58
Revenue
12.39B
Net Profit
1.28B

About Unum Group

Sector
Accident & Health Insurance
Industry
Accident & Health Insurance
Website
www.unum.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Unum Group is listed in the Accident & Health Insurance sector of the Brazil Bovespa Exchange with ticker U1NM34. The last closing price for Unum was R$437. Over the last year, Unum shares have traded in a share price range of R$ 207.48 to R$ 469.95.

Unum currently has 195,046,000 shares outstanding. The market capitalization of Unum is R$85.24 billion. Unum has a price to earnings ratio (PE ratio) of 11.10.

Ask ADVFN Intelligence (AI)

U1NM34 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
4-19.3-4.22967346044456.3456.343713437.74230769DR
126116.2234042553376469.9537518398.71143646DR
26135.2244.8074756445301.78469.95300.84112315.34301136DR
52229.52110.622710623207.48469.95207.4882313.61616078DR
156296.56211.164910282140.44469.95131.09447198.01396123DR
260334.31325.552634142102.69469.9551.31737155.13982251DR

U1NM34 - Frequently Asked Questions (FAQ)

What is the current Unum share price?
The current share price of Unum is R$ 437.00
How many Unum shares are in issue?
Unum has 195,046,000 shares in issue
What is the market cap of Unum?
The market capitalisation of Unum is BRL 85.24B
What is the 1 year trading range for Unum share price?
Unum has traded in the range of R$ 207.48 to R$ 469.95 during the past year
What is the PE ratio of Unum?
The price to earnings ratio of Unum is 11.1
What is the cash to sales ratio of Unum?
The cash to sales ratio of Unum is 1.15
What is the reporting currency for Unum?
Unum reports financial results in USD
What is the latest annual turnover for Unum?
The latest annual turnover of Unum is USD 12.39B
What is the latest annual profit for Unum?
The latest annual profit of Unum is USD 1.28B
What is the registered address of Unum?
The registered address for Unum is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Unum website address?
The website address for Unum is www.unum.com
Which industry sector does Unum operate in?
Unum operates in the ACCIDENT & HEALTH INSURANCE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AZEV11Azevedo Travassos Sa
R$ 0.28
(47.37%)
42.2k
JFEN3Joao Fortes Engenharia Sa
R$ 2.71
(18.34%)
239.56k
VLID3Valid Solucoes E SV De SEG EM Meios
R$ 25.00
(16.28%)
749.17k
AERI3Aeris Industria E ComerciodeEquipamentos paraGeracaodeEnergiaS.A
R$ 7.94
(13.43%)
935.03k
PINE3Banco Pine SA
R$ 4.94
(12.02%)
13.1k
COCE11Cia Energetica Ceara Coelce
R$ 0.62
(-35.42%)
10.7k
RADL3QRaia Drogasil SA
R$ 21.46
(-11.07%)
138k
AALR3Allianca Saude e Participacoes S.A.
R$ 7.27
(-9.13%)
67.2k
OFSA3Ourofino S.A
R$ 16.01
(-8.83%)
6.9k
FICT3Fictor Alimentos S.A.
R$ 3.03
(-8.18%)
39.3k
POMO4Marcopolo Sa
R$ 7.35
(-4.05%)
24.33M
CMIN3CSN Mineracao S.A
R$ 4.88
(-3.17%)
19.02M
ITUB4Itau Unibanco Holding SA
R$ 29.82
(-2.45%)
14.89M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.10
(-3.23%)
13.92M
PETR3Petroleo Brasileiro S.A. Petrobras
R$ 40.38
(-0.35%)
12.65M

Discussion

View Full Feed
devil dog 96 devil dog 96 4 minutes ago
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 4 minutes ago
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 8 minutes ago
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 8 minutes ago
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 28 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 31 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 32 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 32 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 33 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 35 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 36 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 37 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 38 minutes ago
Probably
AVXL
HokieHead HokieHead 40 minutes ago
Wrong..
TWOH
HokieHead HokieHead 40 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 42 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 43 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 43 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 44 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 45 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 46 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 46 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 49 minutes ago
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL

Your Recent History

BOV
U1NM34
Unum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads